Harrow Weald, United Kingdom

Bhupinder P Singh Khambay

This inventor holds 1 USPTO granted patent. Top assignee: National Research Development Corporation. Active years: 1988.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bhupinder P Singh Khambay. Retrieved from https://idiyas.com/inventor/bhupinder-p-singh-khambay

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1988

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bhupinder P Singh Khambay: Innovator in Pesticidal Compounds

Introduction

Bhupinder P Singh Khambay is a notable inventor based in Harrow Weald, GB. He has made significant contributions to the field of pesticides, particularly with his innovative formulations.

Latest Patents

Khambay holds a patent for "Phenyl phenoxyphenyl propenyl cyclopropane pesticides." This patent involves pesticidal compounds of a specific formula, showcasing his expertise in developing effective agricultural solutions.

Career Highlights

He is associated with the National Research Development Corporation, where he applies his knowledge and skills to advance research in pesticide development. His work has been instrumental in creating safer and more effective pest control methods.

Collaborations

Khambay has collaborated with notable colleagues, including Michael Elliott and Norman F Janes. These partnerships have contributed to the success of his projects and innovations.

Conclusion

Bhupinder P Singh Khambay's work in the field of pesticides exemplifies his commitment to innovation and research. His contributions continue to impact agricultural practices positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…